Copper Transporter CTR1 as a Predictive Biomarker and Therapeutic Target in Platinum Resistance
The identification of reliable biomarkers for predicting response to platinum-based chemotherapy is essential for personalizing cancer treatment and improving patient outcomes. Among the emerging candidates, copper transporter receptor 1 (CTR1)…